CIDRAP newsletters options
Interim phase 1-2a results from Johnson & Johnson's COVID-19 vaccine trials show that its vaccine, Ad26.COV2.S, produces a good immune response and safety profile, according to a New England Journal of Medicine study yesterday.
Patients not needing ventilators who were given high-titer plasma had a 34% lower risk of death within 30 days.
Also, the WHO says its COVID-19 emergency committee will meet tomorrow for the sixth time.
And in a new study, CDC data show more cases in kids as schools reopened, but only limited school outbreaks.
Almost half (45.4%) of intensive care unit (ICU) physicians, nurses, and other healthcare workers in England reported a mental disorder during the pandemic, including suicidal thoughts, according to survey results published in Occupational Medicine yesterday.
UK hospitals in the hardest-hit areas are struggling, and deaths are up 46% in the past week.
Merck's Ervebo vaccine is currently the sole stockpile product, with a planned-for 500,000 doses.
"We're telling states now to vaccinate their most vulnerable people."
The cumulative pediatric hospitalization rate jumped from 2.0 per 100,000 children in May to 7.2 in November.
Shawano County, Wisconsin, had its first confirmed case of chronic wasting disease (CWD) in wild deer, according to a WBAY news story yesterday. CWD is a fatal, prion-caused neurologic disease affecting the deer family.
Nonwhite Americans, those with low incomes or less than a high school education, and veterans were much more likely to die of COVID-19 than others in a simulation study published yesterday in PLOS Medicine, backing the findings of previous research.
As the world sees its deadliest day of the pandemic so far, China announces dates for a mission to arrive to probe origins of the virus.
Symptoms like fatigue, breathing problems persisted in 76% of patients.
California, Arizona, Oklahoma, South Carolina, and Rhode Island have the highest case rates.
In New York City, deaths caused by ischemic heart disease increased 139% during the pandemic.
In COVID-19 patients admitted to intensive care units (ICUs) early in the pandemic, 82% were in a comatose state at some point and 55% experienced delirium, reports a Lancet study published late last week. Previous studies have connected ICU delirium to higher costs, greater mortality risk, and long-term dementia.
A new study led by researchers with Pfizer shows a substantial burden of extraintestinal invasive Escherichia coli infections (IEIs) in the United States, with increasing resistance to extended-spectrum cephalosporins.
Also, the Biden team proposes a new COVID-19 vaccine distribution plan.
Studies spotlight limited in-school COVID-19 spread in North Carolina, Sweden, and Norway.
"Vaccine nationalism hurts us all and is self-defeating."
